DPG Mitgliedschaft

This block is broken or missing. You may be missing content or you might need to enable the original module.

Keyword: Boehringer Ingelheim

News

The Transition to Digitalization in the Pharmaceutical Industry

15.09.2021 -

ISPE and its members are developing the roadmap to introduce Industry 4.0, also called the Smart Factory, at the pharmaceutical industry as Pharma 4.0 – an operating...

News

Expert Statement: Viola Meisterling, Boehringer Ingelheim

06.09.2021 -

ISPE and its members are developing the roadmap to introduce Industry 4.0, also called the Smart Factory, at the pharmaceutical industry as Pharma 4.0 – an operating...

News

Boehringer Ingelheim and Enara Bio in Cancer Pact

25.01.2021 -

German drugmaker Boehringer Ingelheim and UK biotech Enara Bio have agreed to collaborate on the research and development of novel targeted cancer immunotherapies...

Chemistry & Life Sciences

The Impact of Covid-19 on the Pharmaceutical Industry

31.08.2020 -

Andrew Badrot, CEO of C2 Pharma and a close observer of pharma industry trends, analyzes the current situation and how this pandemic may kick of changes in the pharma...

Plant Construction & Process Technology

Technology and Innovation in the Pharmaceutical Industry

14.04.2020 - Established in 2004 by the International Society for Pharmaceutical Engineering (ISPE), the Facility of the Year Awards (FOYA) recognize innovation and creativity in manufacturing...

Markets & Companies

Injecting Growth and Innovation

13.09.2019 - Abbvie takes over Allergan, Pfizer merges its generics business with Mylan, Takeda integrates Shire — the pharmaceutical industry is making a name for itself in 2019 with several...

Plant Construction & Process Technology

Live-Broadcasting of Bioprocesses

10.09.2019 - The quality specifications of biopharmaceuticals are enormous and require a long list of time-consuming analytics. A big disadvantage of these analytics so far was, that their...

News

Boehringer Ingelheim Expanding in Mexico

28.05.2019 - German drugmaker Boehringer Ingelheim is planning to invest around 1.6 billion pesos (about $84 million) at its three manufacturing sites in Mexico over the next two years, with...

Ehrenamtliches Engagement

This block is broken or missing. You may be missing content or you might need to enable the original module.